Lobbying firm

PHARMATHENE, INC

Biotechnology research, development and manufacturing. Biodefense vaccines/therapeutics

Filings
43
Clients
1
Total income
—
Lobbyists
2
Years active
2007–2016

Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.

Income by year

Fees reported, $ thousands 2007 to 2016

Filings

43 filings, newest first.
Filing Client Income Expenses
1st Quarter - Termination (No Activity)
1st Quarter 2016, no activity
PHARMATHENE, INC — income — expenses
4th Quarter - Report (No Activity)
4th Quarter 2015, no activity
PHARMATHENE, INC — income — expenses
3rd Quarter - Report (No Activity)
3rd Quarter 2015, no activity
PHARMATHENE, INC — income — expenses
1st Quarter - Termination (No Activity)
1st Quarter 2015, no activity
PHARMATHENE, INC — income — expenses
4th Quarter - Report
4th Quarter 2014
PHARMATHENE, INC — income $10,000 expenses
3rd Quarter - Amendment
3rd Quarter 2014
PHARMATHENE, INC — income — expenses
3rd Quarter - Reportreplaced
3rd Quarter 2014
PHARMATHENE, INC — income — expenses
2nd Quarter - Report
2nd Quarter 2014
PHARMATHENE, INC — income $53,000 expenses
1st Quarter - Report
1st Quarter 2014
PHARMATHENE, INC — income $84,512 expenses
4th Quarter - Report
4th Quarter 2013
PHARMATHENE, INC — income $76,358 expenses

Clients

Everyone this filer has reported for, with the reports filed and the income they disclose.

ClientReportsIncome
PHARMATHENE, INC 33 —

Lobbyists

Everyone named on this filer's reports, with the government post they most recently disclosed here.

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. VP Policy and government Affairs
MARK EDWARD COOKE Sr. Director Government Affairs

From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.